ストックスクリーナーアプリを入手
333.96
0.75%
2.47
アフターアワーズ：
333.96
Amgen Inc (AMGN) 最新ニュース
Does FDA’s UPLIZNA gMG Expansion Reshape the Bull Case for Amgen’s Diversification Story (AMGN)? - simplywall.st
Brookstone Capital Management Acquires 16,042 Shares of Amgen Inc. $AMGN - MarketBeat
Farther Finance Advisors LLC Buys 3,158 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know - The Globe and Mail
Swedbank AB Sells 283,479 Shares of Amgen Inc. $AMGN - MarketBeat
Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity? - Yahoo Finance
Amgen Inc. $AMGN Shares Bought by Global X Japan Co. Ltd. - MarketBeat
Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice? - The Globe and Mail
Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN - MarketBeat
Exchange Traded Concepts LLC Has $17.78 Million Position in Amgen Inc. $AMGN - MarketBeat
Is There Still Value in Amgen After Its Strong 2025 Share Price Run? - simplywall.st
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - sharewise.com
Amgen Stock After Hours (AMGN) on Dec. 22, 2025: FDA Clears New Prolia/Xgeva Biosimilars, Fitch Upgrades Credit — What to Know Before the Dec. 23 Open - ts2.tech
Fitch upgrades Amgen to ’BBB+’ on improved financial structure By Investing.com - Investing.com Nigeria
Fitch upgrades Amgen to ’BBB+’ on improved financial structure - Investing.com
Fitch raises Amgen credit rating, outlook stable - breakingthenews.net
Our Workforce - Amgen
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025 - ts2.tech
Amgen’s Pediatric Inebilizumab Study Signals Long-Term Upside in Rare Autoimmune Disease - TipRanks
Matrix Asset Advisors Inc. NY Purchases 4,633 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc (NASDAQ:AMGN) Nasdaq Index Biotechnology Leadership Focus - Kalkine Media
Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Amgen (AMGN) price target trimmed at Morgan Stanley as policy risks ease - MSN
Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025) - ts2.tech
Assessing Amgen (AMGN) Valuation After UPLIZNA Approval and New U.S. Drug Pricing Agreements - simplywall.st
The Best Dividend ETF to Buy: SCHD Pays a High Yield While VIG Focuses on Dividend Growth - The Motley Fool
Sarasin & Partners LLP Buys 47,873 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Foster Victor Wealth Advisors LLC - MarketBeat
Signal Advisors Wealth LLC Has $867,000 Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by CHICAGO TRUST Co NA - MarketBeat
Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts - ts2.tech
Voya Investment Management LLC Sells 275,398 Shares of Amgen Inc. $AMGN - MarketBeat
Bartlett & CO. Wealth Management LLC Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
Has Amgen’s 26% Rally in 2025 Already Priced In Its Obesity and Oncology Ambitions? - Yahoo Finance
Is Amgen Inc. stock a top momentum playWeekly Stock Summary & Daily Stock Trend Watchlist - ulpravda.ru
Amgen to Cut US Drug Prices, Expand Patient Access - marketscreener.com
Amgen takes action with U.S. government to lower medicine costs By Investing.com - ca.investing.com
Amgen says Aimovig & Amjevita to be available at discounted monthly price of $299 under deal with U.S. govt - marketscreener.com
Amgen (AMGN) Moves to Reduce Drug Prices in Collaboration with U - GuruFocus
Amgen Strikes Agreement With US Government to Lower Drug Costs - marketscreener.com
Migraine and arthritis drugs drop to $299 a month under new Amgen plan - Stock Titan
Amgen Advances Olpasiran Heart Plaque Study, Highlighting a Growing Bet on Lipoprotein(a) - TipRanks
Talbot Financial LLC Purchases 5,839 Shares of Amgen Inc. $AMGN - MarketBeat
Bristol Myers, Merck, Amgen among latest to announce U.S. drug pricing deal - Seeking Alpha
Is Amgen Inc. stock trading near support levels2025 Price Momentum & Technical Confirmation Trade Alerts - DonanımHaber
How Amgen Inc. stock reacts to oil pricesJuly 2025 Review & Community Trade Idea Sharing Platform - DonanımHaber
How Amgen Inc. stock performs in weak economy2025 Analyst Calls & Weekly Top Performers Watchlists - Улправда
Chemotherapy Induced Anemia Market Intelligence Report 2025-2032, Featuring Amgen, Johnson & Johnson - PharmiWeb.com
Why Amgen Inc. stock remains on watchlistsJuly 2025 Spike Watch & Free Fast Gain Swing Trade Alerts - Улправда
Czech National Bank Has $38.59 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Inductive Bio, Amgen Join ARPA-H’s Push To Replace Animal Tox With AI And Human Tissues - Citeline News & Insights
Amgen Inc. $AMGN Stock Holdings Lessened by Assenagon Asset Management S.A. - MarketBeat
2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen
Amgen (AMGN) Valuation Check After FDA Expansion of UPLIZNA in Generalized Myasthenia Gravis - Yahoo Finance
HSBC turns more bullish on Amgen (AMGN) into 2026 - MSN
HSBC Turns More Bullish on Amgen (AMGN) into 2026 - Insider Monkey
Amgen (AMGN) Among Pharma Giants in Drug Pricing Talks - GuruFocus
Thurston Springer Miller Herd & Titak Inc. Reduces Stake in Amgen Inc. $AMGN - MarketBeat
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance
Amgen stock rating maintained by Oppenheimer with price target of $380 - Investing.com UK
Sanders Morris Harris LLC Takes $1.21 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Fragasso Financial Advisors Inc - MarketBeat
Amgen (AMGN) Price Target Trimmed at Morgan Stanley as Policy Risks Ease - Insider Monkey
Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts - ts2.tech
0.38%
大文字化:
|
ボリューム (24 時間):